Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Judge combines suits against Pfizer-King merger
Fierce Pharma
Wed, 11/3/10 - 11:46 am
Pfizer
shareholders
King
lawsuits
M&A
Grifols Slumps on The Deal Report That U.S. May Seek to Block Talecris Buy
Bloomberg
Wed, 11/3/10 - 10:47 am
Grifols
Talecris
M&A
The Bottom Line on Why Pfizer Bought Wyeth
WSJ Online
Tue, 11/2/10 - 06:37 pm
Pfizer
M&A
Wyeth
Drugmakers rack up $1B in small deals
Fierce Pharma
Fri, 10/29/10 - 11:53 am
M&A
Sanofi
BMP Sunstone
Teva Pharmaceuticals
Theramex
Merck KGaA
Hikma
Baxter International
Sanofi Hears No `Substance' From Genzyme, Stays Firm on Bid
Bloomberg
Thu, 10/28/10 - 12:25 pm
Genzyme
Sanofi
M&A
Teva to buy Merck KGaA's women's health unit
Reuters
Thu, 10/28/10 - 11:43 am
Women's Health
Teva Pharmaceuticals
M&A
Merck KGaA
Sanofi’s Viehbacher Rules Out $80-a-Share Offer for Genzyme
Bloomberg
Thu, 10/28/10 - 08:06 am
Genzyme
Sanofi
Chris Viehbacher
M&A
In Sanofi-Genzyme Deal, Both Sides Are Dancing Around Bad Information
BNET Pharma
Wed, 10/27/10 - 09:02 am
M&A
Sanofi
Genzyme
Abraxis deal done, Celgene eyes cancer franchise
Fierce Pharma
Mon, 10/25/10 - 12:34 pm
M&A
Celgene
companies
Savient Pharma: No Sale
TheStreet.com
Mon, 10/25/10 - 12:31 pm
M&A
Savient
Alcon names Novartis' Vasella as chairman
Marketwatch
Mon, 10/25/10 - 09:02 am
Daniel Vasella
Novartis
Alcon
M&A
Genzyme Investors Are Urged to Reject Sanofi Offer as Too Low
NY Times, NY
Sat, 10/23/10 - 11:17 am
investors
Genzyme
Sanofi
M&A
How High Could a Sanofi Bid for Genzyme Go?
WSJ Online
Sat, 10/23/10 - 10:41 am
M&A
Genzyme
Sanofi
Genzyme: Company worth $89 a share
Marketwatch
Fri, 10/22/10 - 01:14 pm
Genzyme
M&A
Sanofi
guidance
Genzyme makes case for higher Sanofi deal value
Yahoo/Reuters
Fri, 10/22/10 - 11:25 am
M&A
Sanofi
Genzyme
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Bloomberg
Fri, 10/22/10 - 07:26 am
diabetes
Amylin
Eli Lilly
Cephalon
M&A
Endo
Bydureon
Byetta
Investors to Eli Lilly: Buy or Be Bought
Minyanville
Thu, 10/21/10 - 04:15 pm
investors
M&A
Eli Lilly
Actelion Sets $827 Million Share Repurchase as Takeover Speculation Swirls
Bloomberg
Thu, 10/21/10 - 10:48 am
Actelion
share repurchase
M&A
earnings
Sanofi gets OK from U.S. authorities for Genzyme bid
Yahoo/Reuters
Wed, 10/20/10 - 09:36 am
Sanofi
Genzyme
M&A
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Eli Lilly
M&A
Amylin
Bydureon
diabetes
Alkermes
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »